Yangshengtang Group is not a Fortune 500 company. According to the information of Fortune 500 companies, there is no known Yangshengtang. Yangshengtang Group takes research as the core and industrialization of scientific research achievements as the guidance. There are 63 doctors and postdoctoral fellows, the only hepatitis E vaccine in the world, and the first cervical cancer vaccine independently developed and marketed in China.